935106861
info@markelab.com
Precio
375€ (100 µg)
Mosunetuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3E/MS4A1/CD20, Mosunetuzumab is an investigational, humanized, T-cell bispecific antibody designed to engage T cells and redirect their cytotoxic activity against malignant B cells. Mosunetuzumab simultaneously binds to CD3 epsilon (CD3ε), a component of the T-cell receptor (TCR) complex, and to CD20, a B-cell surface protein expressed in a majority of B-cell malignancies. This results in crosslinking of the TCR, inducing downstream signaling events that lead to B-cell killing.
Biosimilars
Human
Monoclonal
Human
CD3E/MS4A1/CD20
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1905409-39-3
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más